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To understand the influence of the sympathetic nervous system (SNS) on the kidneys, different techniques have been widely used (5, 6, 51) . In an experimental model of increased renal sympathetic nerve activity (rSNA) induced by environmental stress, both urinary retention and sodium retention were completely abolished by renal denervation (35) , demonstrating the role of sympathetic innervation on handling of salt and water by the kidneys. rSNA influences the renal function by increasing renin secretion, decreasing renal blood flow and glomerular filtration rate (GFR), and enhancing tubular sodium reabsorption. Electrical stimulation of the renal nerve (ESRN) induces these responses in a frequency-dependent manner (19) . However, neither renal sodium nor water handling is influenced exclusively by the SNS, since both circulating and local ANG II have direct and indirect actions on renal tubular transport (23, 44, 53) . In fact, ANG II directly increases fluid and bicarbonate reabsorption of proximal tubules in vitro (4) and increases sodium transport in isolated proximal tubules (54) .
Circulating ANG II also acts in brain regions devoid of the blood-brain barrier, leading to SNS activation to the kidney (39, 41) . The positive feedback between ANG II and SNS has been linked to both physiological and pathophysiological conditions (18) . There are clear evidences upon an interdependent between the SNS and ANG II on the kidney (38, 51, 52) . The proximal tubule is responsible for the reabsorption of the majority of filtered sodium, bicarbonate, chloride, and water. The principal apical membrane pathway for sodium reabsorption in the proximal tubule involves an NHE3-mediated Na ϩ /H ϩ exchanger. Apical NHE3 transport also figures prominently in chloride and water reabsorption in the proximal tubule, as isotonic reabsorption occurs across a highly permeable epithelium (2) . NHE3-mediated sodium reabsorption is regulated by various physiological conditions and molecular mechanisms, including phosphorylation, regulatory proteins, and redistribution along brush border microvilli (9).
Healy and colleagues (24) demonstrated that direct electrical renal nerve stimulation has antinatriuretic and antidiuretic effects associated with increased NHE3 activity within the membranes of brush border. However, the signaling and molecular mechanisms underlying such increases, as much as the role of ANG II involved in this response, are not well understood. Because ANG II is an important mediator of sodium reabsorption in the proximal tubule, we tested the hypothesis that intrarenal ANG II may mediate the majority of the antinatriuretic and antidiuretic actions of the rSNA.
METHODS

Materials.
Ketamine and xylazine were obtained from Syntec (Cotia, SP, Brazil). Sodium thiopental was obtained from Cristália (Itapira, SP, Brazil). A monoclonal antibody to NHE3 was a gift from Dr. Peter Aronson (Yale University, New Haven, CT). A phosphospecific mAb that recognizes NHE3 only when it is phosphorylated at serine 552 (PS552) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA) and a mAb to actin (clone JLA20) was purchased from Merck (Darmstadt, Germany). An anti-phosphorylated serine/ threonine (pSer/Thr) PKA substrate antibody was purchased from Cell Signaling Technology (Beverly, MA). Horseradish peroxidaseconjugated goat anti-mouse and goat anti-rabbit secondary antibodies were purchased from Life Technologies (Carlsbad, CA). All other reagents were purchased from Sigma Chemical (St. Louis, MO) unless otherwise stated.
Animals and study design. All experimental procedures were performed in accordance with the guidelines established by the Institutional Animal Care Committee of the Ethics in Research Committee of the Universidade Federal de São Paulo (protocol no. 0361/11). Male Wistar rats (n ϭ 45, 250 -300 g) were obtained from the animal care facility of Universidade Federal de São Paulo. All animals were housed in group cages, given free access to rat chow and water, and maintained in a temperature-controlled environment (23°C) on a 12:12-h light-dark cycle. The animals were anesthetized with ketamine and xylazine (100 and 20 mg/kg ip, respectively), and their right kidneys were retroperitoneally exposed and removed to avoid influence of the contralateral kidney on any observed responses. The animals were allowed to recover until the day of the experiment. After 7-8 days following uninephrectomy, the animals were divided into the following three groups: Sham, in which the animals' rSNA was recorded for 1 h; Stimulated (S), in which the animals were subjected to ESRN for 1 h; and Stimulated and treated with losartan (SL), in which the animals received a single bolus injection of losartan (10 mg/kg iv) 1 h prior to undergoing ESRN. This dose causes tubular natriuresis without causing blood pressure alterations in this condition (25, 61) . At this time, animals were anesthetized with sodium thiopental (60 mg/kg ip) and were subsequently tracheotomized. The femoral vein was catheterized with a PE-10 polyethylene tube, which was connected to a PE-50 for the administration of additional anesthetic (10 mg·kg Ϫ1 ·h Ϫ1 iv) and isotonic saline at 10 ml·kg Ϫ1 ·h
Ϫ1
. The femoral artery was cannulated for direct arterial pressure measurements. The animals' rectal temperature was maintained at 37°C with a servo-controlled electric blanket (Letica). The femoral artery catheter was connected to a pressure transducer, and arterial pressures were recorded online (PowerLab, ADInstruments). The ureter was catheterized with polyethylene tubing (PE-10) to collect urine for posterior analyses.
rSNA in sham rats. The renal nerve was localized by use of a dissecting microscope, freed from connective tissue, and positioned on a bipolar silver recording electrode. Both the renal nerve and electrode were covered with paraffin oil. The signal of the renal nerve was displayed on an oscilloscope and nerve activity was amplified (gain 20,000, Neurolog, Digitimer), filtered with a band-pass filter (100 -1,000 Hz), and collected for display and analysis by using a PowerLab data-acquisition system (ADInstruments).
ESRN. In both the S and SL groups the renal nerve was localized and dissected as described above, and then stimulated at 15 mV, 1.5 Hz, and 0.5 ms over a period of 1 h by using a stimulating electrode connected to an electrical stimulator system (Grass S88). We tested amplitudes to determine the amount sufficient to generate evocated potential from the renal nerve fibers. The median value obtained was 4 mV. Once the evocated potential occurred there was no additional difference in the amplitude of evoked potential, even following increases in voltage stimulation. At the end of the experiments, blood was collected from the femoral artery, and the left kidney was removed and placed in PBS containing 1 tablet/50 ml of Complete Protease Inhibitor Cocktail Tablets (Roche, Mannheim, Germany) and phosphatase inhibitors (50 mM NaF and 15 mM sodium pyrophosphate), pH 7.4.
Analysis of basal rSNA. Nerve activity was analyzed offline with appropriate software (Spike Histogram, ADInstruments). For this purpose, the raw nerve signal was passed through a spike discriminator (PowerLab, ADInstruments) to remove background noise. The number of spikes was counted with a spike discriminator that excluded background noise, which was determined for each experiment (63) .
Blood and urine analyses. At the end of experiment, we collected blood and urine samples to posterior analyses. Urinary flow was determined by measuring urinary volumes normalized to body weight obtained over a period of 1 h. Plasma (PNa) and urinary sodium (UNa) concentrations were measured with an electrolyte analyzer (AVL Medical Instruments). Creatinine clearance was used to estimate GFR. Plasma (P Cr) and urinary creatinine (UCr) concentrations were measured via a kinetic method (Labtest, Minas Gerais, Brazil) using a Thermo Plate Analyzer Plus (Thermo Plate, São Paulo, Brazil). Fractional sodium excretion (FE Na) was calculated as follows: FENa ϭ 100·(U Na/PNa)/(UCr/PCr). We measured urinary angiotensinogen (AGT) using an ELISA (Rat Total Angiotensinogen Assay Kit, Clontech Laboratories) according to the manufacturer's instructions and plasma AGT via immunoblotting. Urinary cAMP was measured by using an ELISA kit (DetectXTM direct cAMP enzyme immunoassay kit, Arbor Assays) according to the manufacturer's instructions (21) .
Cortical renal homogenate and membrane protein isolation. Kidney cortices were isolated at 4°C and homogenized in ice-cold PBS buffer (10 mM phosphate, 140 mM NaCl, pH 7.4) containing protease inhibitors [0.7 mg/ml pepstatin, 0.5 mg/ml leupeptin, 40 mg/ml PMSF, and 1 tablet/50 ml of Complete Protease Inhibitor Cocktail Tablets (Roche)] and phosphatase inhibitors (50 mM NaF and 15 mM sodium pyrophosphate). Aliquots of the crude homogenate were saved for measuring the contents of ANG II, and the remainder was centrifuged at 4,000 g for 10 min at 4°C. The supernatant was removed and subjected to an additional 90 min of centrifugation at 28,000 g at 4°C. The supernatant was discarded, and the pellets were resuspended in fresh PBS containing protease and phosphatase inhibitors. Protein concentrations were measured by Lowry's method (43) .
Determination of ANG II content in renal cortical homogenate. ANG II levels in renal cortical homogenates were measured by competitive ELISA (Phoenix Pharmaceuticals, Burlingame, CA) according to the manufacturer's instructions (50) .
Renal cortical PKA activity. PKA activity was indirectly measured via immunoblotting. Equal amounts (25 g) of plasma membrane protein isolated from rat renal cortices were resolved by SDS-PAGE and analyzed via immunoblotting using a specific antibody that recognizes phosphorylated PKA substrates (16) . Visualized bands were digitized with an Image Scanner (GE HealthCare) and quantified with the Scion Image Software package (Scion, Frederick, MD).
Microvillar membrane vesicle preparation. Rat kidney cortices were isolated at 4°C and homogenized in a K-HEPES buffer (200 mM mannitol, 80 mM HEPES, 41 mM KOH, pH 7.5) containing protease and phosphatase inhibitors. Microvillus membrane vesicles were prepared by a method based on Mg 2ϩ precipitation and differential centrifugation as described previously (1) .
SDS-PAGE and immunoblotting. Renal cortical membrane and microvillar membrane vesicle (MMV) proteins isolated from each of the rat groups and 0.5 l of plasma were solubilized in sample buffer (2% SDS, 20% glycerol, 100 mM ␤-mercaptoethanol, 50 mM Tris, pH 6.8, 0.05% bromophenol blue) and separated by SDS-PAGE using 7.5% polyacrylamide gel. Proteins were then transferred from the polyacrylamide gel to a polyvinylidene difluoride microporous membrane (Immobilon-P, Millipore, Bedford, MA) and incubated by blocking solution (5% nonfat dry milk and 0.1% Tween 20 in PBS buffer, pH 7.0) for 1 h at room temperature to block nonspecific binding before being incubated overnight with 1:500 anti-NHE3, 1:1,000 anti-PS552-NHE3 (monoclonal antibody to serine 552 phosphorylated NHE3), 1:1,000 anti-pSer/Thr, or 1:5,000 anti-actin at 4°C in blocking solution. The membranes were then washed five times in blocking solution and incubated for 1 h with horseradish peroxidase-conjugated immunoglobulin secondary antibody (1:2,000) before being washed and additional five times with blocking solution and subsequently rinsed with either PBS or TBS buffer. Bound antibody was detected via enhanced chemiluminescence (ECL, GE Healthcare, Piscataway, NJ) according to manufacturer's instructions. Visualized bands were dig-itized by using an Image Scanner LAS 4,000 mini (GE Health Care) and quantified with ImageJ software.
Determination of NHE3 activity in MMV. NHE3-mediated Na ϩ /H ϩ exchange activity in MMV was determined by using the acridine orange fluorescent technique as described previously (8) . MMVs (100 g) were resuspended in a 500-l sodium-free buffer containing 140 mM N-methyl-D-glucamine (NMDG) gluconate and 5 mM MES (pH 5.5). Subsequently 20 l of the acid-load MMVs were added to 100 l of 120 mM NMDG-gluconate, 20 mM K-HEPES, pH 7.5, and 6 M acridine orange (Molecular Probes, Eugene, OR). Experiments were performed on a 96-well black plate. The fluorescence signal was monitored and recorded at 0.5-s intervals for 1 min (VICTOR 2 Plate Reader, Perkin Elmer, Waltham, MA). After 2 min, Na gluconate was added to a final concentration of 200 mM per well. Na ϩ /H ϩ exchange activity was defined as the rate of change of acridine orange fluorescence in the presence of sodium per second divided by the initial quenching in the acridine orange fluorescence signal obtained by the addition of the MMV. Each sample was analyzed in triplicate. Some experiments were performed in the presence of 10 M (S3226) (55) . Statistics analysis. All results are reported as means Ϯ SE. Comparisons among groups were performed by one-way ANOVA followed by Newman-Keuls post hoc test. A P value Ͻ 0.05 was considered to be statistically significant.
RESULTS
Experimental characterization.
We performed a right nephrectomy to avoid any influence on our results by the contralateral kidney. As shown in Table 1 , no differences in body Body weight, g 300 Ϯ 8 (n ϭ 6) 307 Ϯ 4 (n ϭ 6) 302 Ϯ 3 (n ϭ 6) Kidney weight, g 1.5 Ϯ 0.1 (n ϭ 6) 1.6 Ϯ 0.1 (n ϭ 6) 1.5 Ϯ 0.01 (n ϭ 6) Ratio, kidney weight/body weightϫ100 0.50 Ϯ 0.02 (n ϭ 6) 0.50 Ϯ 0.02 (n ϭ 6) 0.50 Ϯ 0.01 (n ϭ
Values are means Ϯ SE; n, number of rats per group. S, Stimulated group, in which the animals were subjected to electrical stimulation of the renal nerve (ESRN) for 1 h; SL, Stimulated and treated with Losartan group, in which the animals received a single bolus injection of Losartan (10 mg/kg iv) 1 h prior to undergoing ESRN; MAP, mean arterial blood pressure; rSNA, renal sympathetic nerve activity. Fig. 1 . Effects of acute electrical stimulation of the renal nerve (ESRN) on urinary and circulating angiotensinogen (AGT) levels. A: circulating angiotensinogen levels were determined via immunoblotting. Top: an equal volume of plasma (0.5 l) from each animal was subjected to SDS-PAGE, transferred to a polyvinylidene difluoride (PVDF) membrane, and incubated with a polyclonal antibody against angiotensinogen. Membranes were stained with Ponceau S prior to antibody incubation, and the protein albumin was used as an internal control. There was no difference in circulating angiotensinogen among the groups. Bottom: the relative abundance of angiotensinogen/albumin was quantitated via densitometry. B: urinary angiotensinogen levels were determined via ELISA. The number of rats in each group is depicted within the bar graphs. Compared with Sham group, activity of the intrarenal renin-angiotensin system (RAS) was increased by ESRN [98% higher in acute ESRN (S) and 100% in acute ESRN pretreated with losartan (SL) groups] (Fig. 1B) . C: renal cortical ANG II levels were determined via competitive ELISA. ANG II were significantly higher (304% in S and 337% in SL) compared with Sham. Values are means Ϯ SE. *P Ͻ 0.05 vs. Sham. Values are means Ϯ SE. *P Ͻ 0.05 vs. Sham. weight, kidney weight, and ratio of kidney weight to body weight were observed among the three experimental groups following uninephrectomy. Each of the groups demonstrated similar basal blood pressures and rSNA. Neither S nor SL groups demonstrated alterations in blood pressure during the experiment, similar to the Sham group (Table 1) .
ESRN activates intrarenal but not systemic renin-angiotensin system. AGT is a valuable marker of the renin-angiotensin system (RAS) in humans and rodents (27, 31) . Plasma AGT represents systemic RAS, and urinary AGT represents intrarenal RAS. We evaluated the effects of ESRN on both circulating and urinary AGT to determine whether increased rSNA would lead to activation of either the intrarenal or systemic RAS. As illustrated in Fig. 1A , ESRN caused no changes in systemic RAS. However, compared with the Sham group, the activity of the intrarenal RAS was increased in both the S and SL groups by 98 and 100%, respectively (Fig. 1B) .
To further confirm the effect of ESRN on renal RAS, the content of ANG II was measured in renal cortical homogenates by competitive ELISA. Similar to urinary AGT, the levels of ANG II were significantly higher in both S (1.55 Ϯ 0.16 vs. 0.51 Ϯ 0.11 ng/g, P Ͻ 0.001) and SL (1.72 Ϯ 0.17 vs. 0.51 Ϯ 0.11 ng/g, P Ͻ 0.001) compared with Sham (Fig. 1C) .
Effects of ESRN on renal function. Figure 2 demonstrates the acute effects of ESRN and ESRN plus losartan on renal function. ESRN significantly reduced urinary flow ( Fig. 2A) and urinary sodium excretion (Fig. 2B) . These antidiuretic and antinatriuretic effects were not accompanied by changes in creatinine clearance (Fig. 2C) . However, ESRN reduced fractional sodium excretion (Fig. 2D) and urinary pH (Fig. 2E) sodium, chloride, and bicarbonate reabsorption that occurs in the proximal tubule of the nephron (46) . Immunoblotting experiments were undertaken to test the hypothesis that ESRN directly affects renal cortical NHE3 expression and phosphorylation levels. As shown in Fig. 3A , total cortical NHE3 expression was unchanged in response to ESRN; however, the ratio of phosphorylated NHE3 to total NHE3 at serine 552 was reduced by as much as 46%. Pretreatment with losartan abolished the effects of ESRN on NHE3 phosphorylation levels.
Phosphorylation at serine 552 represents a mechanism of PKA-mediated inhibition of endogenously expressed NHE3 (34) . Thus the results shown in Figs. 2 and 3 suggest that ESRN increases tubular Na ϩ and water reabsorption by increasing NHE3-mediated Na ϩ /H ϩ exchange via AT 1 . This hypothesis was addressed by measuring NHE3 activity and abundance in MMV isolated from Sham, S, and SL experimental groups (Fig. 4) . Figure 4A shows that ESRN increases NHE3-mediated Na ϩ /H ϩ exchange in MMV by 40 Ϯ 6% compared with Sham. Pretreatment with losartan completely prevented the ESRN-mediated upregulation of NHE3 activity.
Kocinsky and colleagues (34) have found that, when NHE3 is phosphorylated at serine 552, the exchanger is mainly confined to coated pit region of the brush-border membrane. We therefore postulated that reduced PKA-mediated phosphorylation of NHE3 induced by ESRN may lead to redistribution of NHE3 to the microvilli domain of the brush border. Accordingly, as shown in Fig. 4B , NHE3 abundance was 40% higher in MMVs isolated from S rats than in Sham. Additionally, no difference was observed on the abundance of NHE3 in MMV isolated from SL compared with Sham.
The effects of ANG II in the renal tubules are due primarily to the activation of AT 1 receptors, which are present in both apical and basolateral membranes of the proximal tubules. The binding of ANG II to AT 1 receptors at these locations results in the inhibition of adenylyl cyclase and increased Na ϩ reabsorption (56) . Therefore, the reduction of cAMP levels, which results in lower PKA activity, may be one of the mechanisms by which NHE3 is activated by ANG II in response to ESRN. To test this hypothesis, both the urinary concentration of cAMP (Fig. 5 ) and renal cortical PKA activity (Fig. 6) were measured in our experimental groups. As demonstrated in Fig.  5 , ESRN decreased urinary cAMP by 66% and an AT 1 blockade completely abolished the effects of ESRN on urinary excretion of cAMP (88 Ϯ 5 vs. 100 Ϯ 4%, P Ͻ 0.05). Additionally, rats subjected to ESRN exhibited reduced levels of phosphorylated PKA substrates in the renal cortex (Fig. 6 ) compared with Sham rats (60 Ϯ 7 vs. 100 Ϯ 10%). ESRNinduced PKA inhibition was completely blunted by injection of losartan (Sham: vs. S vs. SL: 96 Ϯ 3 vs. 100 Ϯ 10%).
DISCUSSION
The primary finding of the present study was that ESRN increased the NHE3-mediated sodium transport via AT 1 receptor activation. This effect was mediated by the intrarenal RAS and was not influenced by either systemic or renal hemodynamic alterations. Increased NHE3 transport activity induced antinatriuresis and antidiuresis. These responses were completely abolished by the injection of losartan. Therefore, the effects of ESRN on sodium and water reabsorption are highly dependent on the AT 1 receptor.
ESRN decreased both urinary volume and urinary sodium excretion by as much as 61%, and fractional excretion of sodium by as much as 56%, with no change in creatinine clearance. Our functional results were similar to those of prior studies (5, 19) . The possibility that changes in GFR in response to renal stimulation altered sodium reabsorption was ruled out, because we did not observe any changes in creatinine clearance. ESRN below 2 Hz does not cause reduction in renal blood flow or GFR in rats (5, 14, 19) . Furthermore, the levels Fig. 3 . Effects of acute ESRN on renal cortical NHE3 expression and phosphorylation levels in rats treated or not with losartan. Equivalent samples (15 g for NHE3 and 5 g for PS552-NHE3) of renal cortical membranes isolated from Sham rats, rats subjected to acute ESRN (S), and rats subjected to acute ESRN pretreated with losartan (SL) were subjected to SDS-PAGE, transferred to a PVDF membrane, and analyzed via immunoblotting. A: the membranes were incubated with monoclonal antibody against phosphorylated NHE3 at serine 552 (1:1,000), total NHE3 (1:500) and anti-actin (1:5,000). Graphical representation of the relative expression levels of total (B) and phosphorylated (C) NHE3 in renal cortical membranes. The number of rats in each group is depicted within the bar graphs. Values are means Ϯ SE. *P Ͻ 0.05 vs. Sham.
of MAP and rSNA remained stable throughout the experiments. Therefore, the effects of ESRN on renal function were not related to hemodynamic changes.
The renal proximal tubule reabsorbs most of the sodium, bicarbonate, and chloride and water filtered by the glomerulus, which strongly influences both extracellular fluid volume and blood pressure (45) . The primary transporter involved in proximal tubule reabsorption is NHE3 (2). NHE3 reabsorbs sodium and secretes hydrogen (2, 45). As we observed decreases in both urinary sodium and in urinary pH, increased NHE3 transport secondary to ESRN is very likely. Indeed, ESRN increased microvillar NHE3 transport activity by 40%.
The proximal tubule is richly innervated by the sympathetic nerve fibers (3), which strongly suggests that SNS plays an important role at this portion of the nephron. Acute renal denervation reduces proximal tubular reabsorption (6, 13), whereas renal nerve activation increases (5, 36, 51) proximal tubular reabsorption. Therefore, these responses appear to be the result of adrenergic neurotransmitters acting on adrenergic receptors.
The role of the adrenergic receptors in renal proximal tubule volume reabsorption is well established (11, 12) . The microperfusion of norepinephrine in peritubular capillaries increased the proximal reabsorption of bicarbonate (11) and water (12), a process that was completely abolished by the ␣-adrenoceptor antagonist phenoxybenzamine. Interestingly, the infusions of norepinephrine and phenoxybenzamine into the proximal tubule did not change fluid and bicarbonate reabsorption rates, clarifying the role of adrenoceptors at the basolateral membrane as regulators proximal tubular reabsorption (11, 12) .
A previous study demonstrated that acute denervation or ANG converting enzyme inhibitor decrease the rates of proximal tubule volume reabsorption at the same magnitude. However, intratubular infusions of ANG II restored proximal reabsorption to basal levels, even in the absence of renal innervation, demonstrating the influence of SNS on tonic intrarenal RAS in the setting of acute conditions (52) . Accordingly, the antinatriuretic and antidiuretic effects observed in the present Fig. 5 . Effects of acute ESRN on renal urinary excretion of cAMP in rats treated or not with losartan. cAMP urine concentration from Sham rats, rats subjected to acute ESRN (S), and rats subjected to acute ESRN pretreated with losartan (SL) was evaluated by ELISA and then adjusted for urinary flow. The number of rats in each group is depicted within the bar graphs. Values are means Ϯ SE. *P Ͻ 0.05 vs. Sham. Fig. 4 . Effects of acute ESRN on NHE3 activity and abundance in apical microvillar membrane vesicles (MMV) isolated from rats treated or not with losartan. A: NHE3 activity was measured in MMV from Sham rats, rats subjected to acute ESRN (S), and rats subjected to acute ESRN pretreated with losartan (SL) as the reappearance of acridine orange from acid-loaded MMVs. Experiments were performed in the presence or absence of the specific NHE3 inhibitor S3226 (10 mM). Each sample was analyzed in triplicate, and the mean value of 4 -5 rats from each group was calculated. B, top: NHE3 protein abundance in MMV was evaluated by immunoblotting. Equal amounts of protein (10 g) from each animal were subjected to SDS-PAGE, transferred to a PVDF membrane, and incubated with the antibody anti-NHE3 (clone 3H3) (1:500) or actin (1:50,000). Bottom: graphical representation of the relative expression levels of NHE3 in MMV. The number of rats in each group is depicted within the bar graphs. Values are means Ϯ SE. *P Ͻ 0.05 vs. Sham. study were dependent on the AT 1 receptors. Moreover, present study demonstrated that AT 1 receptors are involved in NHE3-mediated sodium reabsorption in response to ESRN. In line with our findings it has been demonstrated that AT 1 blockade prevented nerve-mediated antinatriuresis and antidiuresis following air-jet stress (58) . The same group later postulated the term "functional denervation" after they observed that an AT 1 blockade blunted volume retention in experimental cirrhotic rats exposed to an acute volume load (57) . Our functional data confirmed the interaction between the SNS and ANG.
In the present study, we demonstrated that the ESRNmediated increases in NHE3-mediated sodium reabsorption are due to increased intrarenal ANG II (Fig. 7) . The binding of ANG II to its corresponding receptors results in the inhibition of adenylyl cyclase and in increased Na ϩ reabsorption (56). NHE3 is inhibited via phosphorylation by PKA (15, 34, 64) , and reductions in cAMP levels may be one of the mechanisms by which NHE3 is activated by ANG II (42, 59) . Accordingly, we observed that ESRN activates the intrarenal RAS, decreases urinary cAMP excretion, and reduces renal cortical PKA activity. ESRN also decreases the ratio of NHE3 PS552/total NHE3 but does not affect total NHE3. Therefore, our results strongly support the proposed mechanism shown in Fig. 7 in which ANG II couples with an inhibitory G protein and subsequently reduces cAMP synthesis, resulting in reduced PKA-mediated inhibition of NHE3.
The phosphorylation of NHE3 at serine 552 has been implicated in NHE3 subcellular redistribution (22) . Kocinsky and colleagues (33) demonstrated that NHE3 phosphorylated at serine 552 predominantly localizes to the coated pit domain of the brush border. Recently, Brasen and colleagues (10) developed a mathematical model suggesting that NHE3 localized exclusively at the base of the brush border results in local pH microdomains, which reduces NHE3 activity by Ͼ30%. Our results demonstrate that ESRN increases NHE3 abundance in MMV without altering total cortical NHE3 expression, strongly suggesting that ESRN modulates NHE3 subcellular distribution. Accordingly, studies by the McDonough (62), Yip (40) , and Johns (24) groups demonstrated that NHE3 redistributes from the base to the body of the microvilli in response to rSNA activation. Therefore, it appears that lower levels of NHE3 phosphorylation at serine 552 triggered by ESRN/ANG II/AT 1 activation may be necessary to increase the distribution of the exchanger in the body of the microvilli and subsequently bolster its transport capabilities.
ESRN increased urinary AGT but not plasma AGT. Urinary AGT is a valuable marker of intratubular RAS in human pathophysiological conditions (28) and in rats under experi- Fig. 6 . Effects of acute ESRN on renal cortical activity of PKA in rats treated or not with losartan. Phosphorylation levels of PKA substrates in renal cortical plasma membranes of Sham rats, rats subjected to acute ESRN (S), and rats subjected to acute ESRN pretreated with losartan (SL) were evaluated via immunoblotting. A: equal amounts of protein (15 g) from each animal were subjected to SDS-PAGE, transferred to a PVDF membrane, and incubated with the antibody anti-phosphorylated serine/threonine (pSer/Thr). Actin was used as an internal control. B: the sum total of all phospho-PKA proteins per lane was estimated via densitometry and normalized by actin. The combined data from 5 rats per group are represented as columns in a bar graph. Values are means Ϯ SE. *P Ͻ 0.05 vs. Sham group. mental conditions (47) . In both chronic hypertensive humans (49) and rats (32) , AT 1 antagonist treatment decreased urinary AGT probably via inhibition of positive feedback mechanism by ANG II (29, 30, 32, 47) . We found that a single injection of losartan followed by ESRN increased urinary AGT. We believe that the positive feedback by ANG II did not occur in our condition considering that we performed our experiments acutely in normotensive rats. ESRN increased urinary AGT as well as renal cortical ANG II content in both the S and SL groups at the same magnitude. These results indicate that ESRN increases intrarenal RAS, even in the presence of an AT 1 receptor blockade. In fact, SNS increases the activity of the intrarenal RAS independently of alterations in plasma (48) . Furthermore, it also indicates that functional and molecular changes induced by the ESRN were due to the AT 1 receptor rather than intrarenal RAS activation. These finds firmly establish that increases in NHE3 transport by ANG II occur primarily via AT 1 receptors.
Altogether, our results demonstrate that acute physiological increases in rSNA activate intrarenal AT 1 receptors, which subsequently increases NHE3-mediated transport and results in antinatriuresis and antidiuresis. 
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